✦ LIBER ✦

Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan

✍ Scribed by J. Vela-Ojeda; M. A. García-Ruiz-Esparza; Y. Padilla-González; D. Gómez-Almaguer; C. H. Gutiérrez-Aguirre; D. Gómez-Rangel; A. Morales-Toquero; G. J. Ruiz-Delgado; J. L. Delgado-Lamas; G. J. Ruiz-Argüelles

Book ID: 105988883
Publisher: Springer
Year: 2007
Tongue: English
Weight: 131 KB
Volume: 86
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-006-0235-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Myeloma cell contamination of peripheral

Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

✍ Wichard Vogel; Hans-Georg Kopp; Lothar Kanz; Hermann Einsele 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 245 KB

Phase I/II study of tandem high-dose che

Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma

✍ Kazutaka Sunami; Katsuji Shinagawa; Morio Sawamura; Akira Sakai; Yoshio Saburi; 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 277 KB

High-dose melphalan versus busulfan, cyc

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

✍ Don M. Benson Jr.; Patrick J. Elder; Thomas S. Lin; William Blum; Sam Penza; Bel 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Viable CD34+/CD133+ blood progenitor cel

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

✍ C. Hicks; R. Wong; A. Manoharan; Y. L. Kwan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Assessing the charges associated with he

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

✍ Chitra Hosing; Veronica Smith; Beverly Rhodes; Kent Walters; Richmond Thompson; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Cardiac toxicity of high-dose cyclophosp

Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation

✍ Samo Zver; Vesna Zadnik; Peter Černelč; Mirta Koželj 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 298 KB